Cro services in

Diabetes

At Gubra we have decades of scientific expertise in conducting preclinical studies using animal models of type 2 diabetes. We can provide end-to-end study design, and comprehensive data combining in vivo metabolic profiling with hormonal analysis, histology and RNAseq to evaluate the impact of your anti-diabetic drug candidate.

Why choose Gubra?

Expert scientific guidance within diabetes
Extensive experience in anti-diabetic drug profiling
Golden standard type 2 diabetic rodent models
Tailored study design and rapid initiation
Combination of pharmacology and histology

Consult with Marco Tozzi

Senior Scientist, Scientific Sales

Advance your diabetes drug development with our extensive knowhow.

Decades of experience in anti-diabetes drug profiling

We have extensive knowhow in conducting preclinical studies using animal models of type 2 diabetes. Our technical expertise includes working with difficult models such as ZDF rats or db/db mice as well as quantifying beta-cell mass and other histological-pathological endpoints of diabetes.

Main Offerings

Diabetic rodent models

Treatment efficacy studies

Full metabolic
assessment services

Glucose homeostasis
evaluation

Insulin sensitivity testing

Islets and β-cells
quantification

We work with the common models of diabetes

Models of Diabetes

db/db mouse

Deficient leptin receptor signalling
Morbid obesity and impaired glucose tolerance
Early phenotype of type 2 diabetes
Well-defined progression in islet pathology
Suitable for treatment intervention
Validated with several anti-diabetic drug classes

Learn more

ZDF rat

Deficient leptin receptor signalling
Morbid obesity and impaired glucose tolerance
Early phenotype of type 2 diabetes
Well-defined progression in islet pathology
Suitable for treatment intervention
Validated with several anti-diabetic drug classes

Learn more

Cloud-based data viewer

GubraView

Our cloud-based data viewer GubraView provides instant access to study data as it is uploaded, ensuring seamless monitoring throughout your study. With features for cross-group and cross-study comparisons, GubraView enables informed decision-making with statistical analyses. Accessible across multiple locations, GubraView empowers efficient and collaborative drug development for your whole team.